ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Phoenix Biotech Aquisition Corporation

Phoenix Biotech Aquisition Corporation (PBAX)

5,85
0,00
(0,00%)
Geschlossen 21 Dezember 10:00PM
0,00
0,00
(0,00%)
Nach Börsenschluss: -

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
5,85
Gebot
5,00
Fragen
5,85
Volumen
-
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
Handelsende
5,85
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
6.246.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-14,41
Gewinn pro Aktie (EPS)
-0,41
Erlöse
-
Nettogewinn
-2,54M

Über Phoenix Biotech Aquisition Corporation

Phoenix Biotech Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company intends to pursue an acquisition opportuni... Phoenix Biotech Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company intends to pursue an acquisition opportunity in any business, industry, sector or geographical location, industries that complement management team's background, and to capitalize on the ability of management team to identify and acquire a business in the healthcare or healthcare related industries in the United States and Europe. Mehr anzeigen

Sektor
Blank Checks
Branche
Blank Checks
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-

PBAX Neueste Nachrichten

Phoenix Biotech Acquisition Corp. and CERo Therapeutics, Inc. Announce Close of Business Combination

Phoenix Biotech Acquisition Corp. (NASDAQ:PBAX) (“PBAX”) and CERo Therapeutics, Inc., an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics...

CERo Therapeutics, Inc. and Phoenix Biotech Acquisition Corp. Announce Merger Agreement to Create Public Company Advancing the Development of Next Generation Engineered T Cell Therapeutics

CERo is an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms. Its lead product candidate is expected to...

Phoenix Biotech Acquisition Corp. Class A Common Shares and Warrants to Commence Trading Separately on November 26, 2021

Oakland, CA, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Phoenix Biotech Acquisition Corp. (NASDAQ:PBAXU) (the “Company”), a blank-check company formed for the purpose of acquiring or merging with one or...

Phoenix Biotech Acquisition Corp. Announces Completion of $175,000,000 Initial Public Offering, Including Exercise of Over-Allotment Option

Oakland, CA, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Phoenix Biotech Acquisition Corp. (NASDAQ:PBAXU) (the “Company”), a blank-check company formed for the purpose of effecting a merger, share...

Phoenix Biotech Acquisition Corp. Announces Pricing of $155,000,000 Initial Public Offering

Oakland, CA, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Phoenix Biotech Acquisition Corp. (NASDAQ:PBAXU) (the “Company”), a blank check company formed for the purpose of effecting a merger, share...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

PBAX - Frequently Asked Questions (FAQ)

What is the current Phoenix Biotech Aquisition share price?
The current share price of Phoenix Biotech Aquisition is US$ 5,85
How many Phoenix Biotech Aquisition shares are in issue?
Phoenix Biotech Aquisition has 6.246.000 shares in issue
What is the market cap of Phoenix Biotech Aquisition?
The market capitalisation of Phoenix Biotech Aquisition is USD 36,54M
What is the 1 year trading range for Phoenix Biotech Aquisition share price?
Phoenix Biotech Aquisition has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of Phoenix Biotech Aquisition?
The price to earnings ratio of Phoenix Biotech Aquisition is -14,41
What is the reporting currency for Phoenix Biotech Aquisition?
Phoenix Biotech Aquisition reports financial results in USD
What is the latest annual profit for Phoenix Biotech Aquisition?
The latest annual profit of Phoenix Biotech Aquisition is USD -2,54M
What is the registered address of Phoenix Biotech Aquisition?
The registered address for Phoenix Biotech Aquisition is RODNEY SQUARE, 1000 NORTH KING STREET, WILMINGTON, DELAWARE, 19801
What is the Phoenix Biotech Aquisition website address?
The website address for Phoenix Biotech Aquisition is www.cero.bio/
Which industry sector does Phoenix Biotech Aquisition operate in?
Phoenix Biotech Aquisition operates in the BLANK CHECKS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
120,01M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
76,64M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
33,95M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,61k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
120,4M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,91M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,75M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,94M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
9,27M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
6,25M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,32M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
305,1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
292,16M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
287,21M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
277,63M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock